B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy
-
* Corresponding author: Juan C Aguillón jaguillo@med.uchile.cl
Arthritis Research & Therapy 2010, 12:R68 doi:10.1186/ar2985
See related editorial by Mauri and Jury, http://arthritis-research.com/content/12/4/133
Accesses
- Last 30 days: 68 accesses
- Last 365 days: 786 accesses
- All time: 2698 accesses
Cited by
BioMed Central: 1 citation
|
Claudia Mauri, Elizabeth C Jury Arthritis Research & Therapy 2010, 12:133 (13 August 2010) |